부산대학교 도서관

This document discusses the importance of drug safety and effective communication in pharmacovigilance, particularly during public health emergencies like the COVID-19 pandemic. It highlights the limitations of clinical trials and the need for real-world evidence to bridge the gaps in drug efficacy and safety. The document features a collection of studies that emphasize the role of pharmacovigilance and pharmacoepidemiology in assessing the benefit-risk profile of drugs and providing insights into long-term effects, disease response, drug utilization patterns, and adverse events. These studies aim to ensure patient safety, guide evidence-based decision making, and optimize therapeutic approaches for individual patients. [Extracted from the article]